RS
IMCR icon

R Squared’s Immunocore IMCR Stock Holding History

R Squared’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,849
Closed -$307K – 574
2025
Q4 		$307K Buy
8,849
+606
+7% +$21.4K 0.14% 223
2025
Q3 		$299K Buy
+8,243
New +$280K 0.13% 251
2025
Q1 		– Sell
-350
Closed -$10.3K – 857
2024
Q4 		$10.3K Buy
+350
New +$11.1K 0.01% 1142

Other funds holding IMCR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

R Squared's IMCR Position: Q1 2026 in Review

R Squared sold out of Immunocore (IMCR) in Q1 2026, closing a stake of 8,849 shares — an estimated $307K sold.

R Squared first reported a position in IMCR in Q4 2024 and held it in 3 quarters. The position peaked at $307K in Q4 2025. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

  • R Squared reported no remaining Immunocore position as of Q1 2026 after selling out during the quarter.
  • R Squared sold 8,849 Immunocore shares in Q1 2026, an estimated $307K.
  • R Squared first reported a position in Immunocore in Q4 2024 and held it in 3 quarters.
  • R Squared's Immunocore position peaked at $307K in Q4 2025.
  • 142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on R Squared's 13F filing for Q1 2026, filed 29 Apr 2026.